COMPARISON OF QUALITY CONTROL OF TWO DIFFERENT B-COMPLEX TABLETS AND THEIR LEGISLATIVE ISSUES ON THE ALBANIAN PHARMACEUTICAL MARKET

Abstract

The aim of this study is to compare two different productions of Albanian and Canadian B-complex multivitamin tablets on the Albanian pharmaceutical market through various ‘in vitro’ pharmacopeias tests and argue about the regulatory legislative framework of drugstore sale of these products. Identification, weight uniformity, hardness and disintegration tests are carried out for the specific vitamins pyridoxine, niacin and riboflavin in these multivitamin B-complex tablets. The quality control tests implemented for the different productions of Albanian and Canadian B-complex tablets ensues that both of the productions fulfill the limits of pharmacopoeia for the presented tests. In the comparison of these products, it is noticed difference in technological formulation, packing and price per tablet. The retrospective analysis of the legislative framework shows a gap in the marketing and sale protection for these multivitamin tablets as genuine pharmaceutical products.